.After having a look at period 1 data, Nuvation Bio has chosen to halt work with its one-time top BD...
.Zevra Therapeutics' uncommon health condition drug seems to become on the road to approval this los...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment failing has actually gone a $230 t...
.After more than 20 years of work with neurodegenerative diseases, Swiss biotech a/c Immune system c...
.GSK has broken up a phase 2 individual papillomavirus (HPV) vaccine from its pipe after determining...
.Operating system Therapies are going to specify on the NYSE American stock exchange today by means ...
.ALX Oncology's period 2 gastric cancer action cost has actually compromised. After finding its own ...
.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of expectations, c...
.While Biogen's pharma peers are looking for late-stage properties with little bit of risk, CEO Chri...
.Instil Bio has been a biotech looking for a pipeline after it ditched its own lead properties over ...